Stock Taper
PAVM
PAVMED INC.
NASDAQ
$5.17
▼ DOWN 0.10% (-0.01)

KEY STATISTICS

Market Cap$33.03 M
52w High$28.44
52w Low$3.85
Dividend Yield
Frequency
P/E-0.32
Volume6.03K
Shares Out.6.38M

COMPANY

LEADERSHIP

Lishan Aklog
CHIEF EXECUTIVE
Lishan Aklog

ABOUT

SECTOR
Healthcare
WENT PUBLIC
July 27, 2016
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
41

UPCOMING EARNINGS

DateNov 12, 2026
DayThursday
Rev. Est.$25.00K
NOV
12
THU

SPLIT RECORD

DATETYPERATIO
2026-01-02Reverse1:30
2023-12-07Reverse1:15

PRICE

$5.17 ▼ DOWN 0.10% (−$0.01)
OVERLAYS
$5.10$5.20$5.309:30 AM10:35 AM11:40 AM12:44 PM1:49 PM2:54 PM3:59 PM5.17

About PAVmed Inc.

https://www.pavmed.com ↗

PAVmed Inc. is a U.S.-based medical device company developing innovative products for diagnostics, minimally invasive treatments, and healthcare monitoring across various medical fields.

INDUSTRY

Medical - Devices

A PRODUCT PAVMED INC. IS KNOWN FOR

EsoGuard Esophageal DNA Test
EsoGuard Esophageal DNA Test

EsoGuard is a non-invasive test that analyzes esophageal DNA via the EsoCheck device to detect early esophageal precancer and cancer, with recent U.S. VA contract boosting its market presence.

COMPETITORS

Revenue by Products

IconPRODUCTQ3-2022Q4-2022Q1-2023Q2-2023
Royalty$4K $0 $24K $10K

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity2
Price To Earnings1
Price To Book4
Overall Score2

INSIDER TRADES

OFFICER: CHIEF MEDICAL OFFICER
Lee Victoria Tou-ho
· —
2026-03-24
OFFICER: CHIEF MEDICAL OFFICER
Lee Victoria Tou-ho
Purchase · 70.0K shares
2026-04-02
10 PERCENT OWNER
Tasso Partners, LLC
· 5.4K shares
2026-02-03
10 PERCENT OWNER
Tasso Partners, LLC
· —
2026-03-27

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 1
1 GRADES IN THE LAST 12 MONTHS

SECTORS PEERS

PEERPRICE
ADVB$8.14COMPARE
BNR$9.78COMPARE
HSCS$2.80COMPARE
BMRA$1.61COMPARE
TNON$6.83COMPARE
APVO$2.68COMPARE
SSKN$0.00COMPARE